Cosmetic surgery

 

FREE BLOG Major topics and trends discussed at HBI 2024

HBI’s annual conference took place last week. Almost 600 attendees — comprising CXOs of healthcare providers, investors, suppliers and advisors — travelled from 40 different countries to London for the event. Over the course of three days of roundtables, workshops and panel discussions, they explored the big issues the sector faces, and the opportunities available to the private sector in helping to solve them.

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

Dutch aesthetics chain Faceland exploits sector’s M&A opportunities by buying Italy’s largest chain Juneco

Pan-European Dutch aesthetics chain Faceland is taking advantage of the ample consolidation opportunities in Europe’s rapidly growing aesthetics sector by buying Juneco, Italy’s largest aesthetics chain. This marks Faceland’s first foray into the Italian market and will help the group achieve its plan to grow to over 50 clinics across its five European markets by the end of 2024.

HBI 2024 Day Three, Afternoon Briefing

The afternoon of day three of HBI 2024 included sessions on getting the most out of your data, elderly care, diagnostic labs, and medical aesthetics.

Private pay: Rising – but not as fast as you think

Data from the Private Healthcare Information Network (PHIN) shows the self-pay bubble in the UK seems to have reached its peak. While private pay admissions are still rising across the country, self-pay is out while private medical insurance (PMI) is in.

Find Us